SentryX will be presenting its first clinical results at the upcoming Global Spine Congress in Rio de Janeiro. This international event brings together the global experts in spine surgery. Our presentation, covering the safety and efficacy results of our Phase Ib trial, will take place on Thursday, May 29^th, at 14.30h (Room 2). We look forward to discussing with the audience how the observed reductions in pain and opioid use may help improve the patient journey after spine surgery.

For more details, please visit the Global Spine Congress website.